期刊文献+

一种新型基因芯片技术在人乳头瘤病毒(HPV)高通量基因分型检测的应用研究 被引量:3

A Novel DNA Chip Assay for High-throughput Human Papilomavirus Genotyping
下载PDF
导出
摘要 目前应用比较多的采用反向点杂交/线性杂交方法的人乳头瘤病毒(HPV)基因分型检测方法,操作比较繁琐。该文通过设计针对29种HPV基因型的引物对和特异性探针,对HPV样品进行PCR扩增后,将反向引物生物素标记的PCR产物与固定在HPV基因芯片上的HPV DNA探针杂交、清洗和酶标显色,再对芯片进行图像分析转化为数字信号、确定HPV型别,建立HPV高通量基因分型方法(HPG)。HPV基因芯片大小为0.36 cm2,每个芯片可在96孔板内的小孔中进行杂交和显色。与HCII方法检测的203例样本比较,对13种高危型检测的结果表明,HPG和HCII方法的一致性较好(kappa值0.663),HPG的分析灵敏度更高。显示了高通量快速检测的在大规模流行病调查、疫苗试验和常规诊断的临床应用前景。 Genotyping of human papilomavirus( HPV) by DNA hybridization procedures,such as reverse dot / line bolt( RLB) assay,is well validated but limited because of its laborious process. Based on the primers and specific probes for twenty-nine HPV types,HPV sequences are detected by PCR amplification,subsequent typing by hybridization of the biotinylated PCR products to type-specific oligonucleotide probes coupled to nylon membrane followed by enzyme immunoassay,and final transformation from imaging analyses of DNA Chip to digital signals.The membrane DNA chip is fabricated in a miniaturized size up to 0. 36 centimeter square,so every hybridization can be performed in the individual well on 96 well plates. We compared the performance of HPG to an established HCII assay for thirteen high-risk HPV genotypes on the PCR products derived from 203 clinical samples. The evaluation showed a good agreement( kappa = 0. 663) but also indicated a higher sensitivity of HPG. In conclusion,HPG appears to be highly suitable for large-scale epidemiological studies and vaccination trials as well as for routine diagnostic purposes.
作者 曹友洪
出处 《生物医学工程学进展》 CAS 2013年第3期157-164,167,共9页 Progress in Biomedical Engineering
关键词 基因芯片 乳头瘤病毒 基因分型 DNA chip human papilomavirus genotyping
  • 相关文献

参考文献22

  • 1EM de Villiers,C Fauquet,TR Broker. Classification of papillomaviruses[J].{H}VIROLOGY,2004,(01):17-27.
  • 2Schiffman MH,HM Bauer,RN Hoover. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,1993.958-964.
  • 3Kjaer SK,AJ van den Brule,JE Bock. Human papillomavirus:the most significant risk determinant of cervical intraepithelial neoplasia[J].{H}International Journal of Cancer,1996.601-606.
  • 4Walboomers JMM,Jacobs MV,Manos MM. Huma papillomavirus is a necessary cause of invasive cervical cancer worldwide[J].{H}Journal of Pathology,1999.12-19.
  • 5Zur Hausen,H. Papillomaviruses causing cancer:evasion from host cell control in early events in carcinogenesis[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,2000.690-698.
  • 6Saslow D,Runowicz CD,Solomon D. American Cancer Society guideline for the early detection of cervical neoplasia and cancer[J].{H}CA-A Cancer Journal for Clinicians,2002.342-362.
  • 7Wright TC,Schiffman M,Solomon D. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening[J].{H}OBSTETRICS AND GYNECOLOGY,2004.304-308.
  • 8Schiffman M,Herrero R,Desalle R. The carcinogenicity of human papillomavirus types reflects viral evolution[J].{H}VIROLOGY,2005.76-84.
  • 9Lorincz,A. Hybrid Capture method of detection of human papillomavirus DNA in clinical specimens[J].Papillomavirus Rep,1996.1-5.
  • 10De Roda Husman AM. The use of general primers GP5 and GP6 elongated at their 3 'ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR[J].{H}Journal of General Virology,1995.1057-1062.

同被引文献24

  • 1EM de Villiers;C Fauquet;TR Broker.缺题目[J],{H}VIROLOGY2004(01):17-27.
  • 2Schiffman M H,H M Bauer,R N Hoover. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,1993.958-964.
  • 3Kjaer,S.K,A.J.van denBrule,J.E.Bock. Human papillomavirus:the most significant risk determinant of cervical intraepithelial neoplasia[J].{H}International Journal of Cancer,1996.601-606.
  • 4Walboomers JMM,Jacobs MV,Manos MM. Huma papillomavirus is a necessary cause of invasive cervical cancer worldwide[J].{H}Journal of Pathology,1999.12-19.
  • 5Zur Hausen H. Papillomaviruses causing cancer:evasion from host cell control in early events in carcinogenesis[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,2000.690-698.
  • 6Lorincz A. Hybrid Capture method of detection of human papillomavirus DNAin clinical specim ens[J].Papillomavirus Rep,1996.1-5.
  • 7Gu] S, Murad S,Javed A. Prevalence of high risk human papillomavirus in cervical dysplasia and cancer samples from twin cities in Pakistan[J]. Int J Infect [)is, 2(/15,34 (11) :14-19.
  • 8I.arsson GL, Carlsson J, Karlsson MG, et al. Evaluation ofI-IPV genotyping assays for archival clinical samples[J]. J Mol Diagn,2015,17(3) :293 30I.
  • 9Ingles l)J ,Pierce Campbell CM, Messina JA, et al. Human papillomavirus virus (HPV) genotype and age-specific analyses of external genital lesions among men in the EIPV infection in men (HIM) study~_J]. J Infect Dis, 2015,211(7) :1060-1067.
  • 10Eklund C, Forslund O, Wallin KL, et al. Global improve- mere in genotyping of human papillomavirus DNA: the 2011 fJPV i.abNet International Proficiency Study~J]. J Clin Microbiol, 2014,52 (2) : 449-459.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部